{"disease":{"id":"urinary-tract-infection-complicated","name":"urinary tract infection complicated"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05385536","title":"Evaluating UTI Outcomes in at Risk Populations","phase":"","overall_status":"COMPLETED","enrollment_count":7921,"lead_sponsor_name":"Pathnostics","has_results":false},{"nct_id":"NCT06996301","title":"Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.","phase":"NA","overall_status":"COMPLETED","enrollment_count":773,"lead_sponsor_name":"Doc Lab Inc","has_results":true},{"nct_id":"NCT02166476","title":"Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":550,"lead_sponsor_name":"Melinta Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06885658","title":"Effectiveness of Visual Storytelling Intervention on Antibiotic Adherence in UTI Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":358,"lead_sponsor_name":"Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT03477422","title":"CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"Venus Remedies Limited","has_results":false},{"nct_id":"NCT06946667","title":"Resistance Characteristics and Development of Diagnostic Model for Postoperative UTI in Patients With Kidney Stones","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Xingxin Jiang","has_results":false},{"nct_id":"NCT05905055","title":"P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Meiji Seika Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT02728089","title":"Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}